Clinical characteristics and outcomes of lung cancer with pulmonary embolism.

Abstract:

BACKGROUND:Cancer patients have a higher risk for thrombosis that is usually related to advanced stage and poor prognosis. This study aimed to identify the clinical picture and outcome of non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) patients with pulmonary embolism (PE). PATIENTS AND METHODS:From 1996 to 2005, the clinical presentation of lung cancer patients with PE was evaluated. Their survival was compared with matched controls by log-rank test. RESULTS:A total of 24 patients, 17 men (70.8%) and 7 women (median age: 62.5 years), were identified. Nineteen patients (79.2%) initially presented with advanced lung cancer (16 stage IV, 1 stage III-b NSCLC and 2 extensive-stage SCLC). Wells' clinical prediction score for PE only predicted moderate probability (median: 5.25). In patients with PE, survival was significantly shorter than in matched control patients (243.5 vs. 327 days, p = 0.01). This difference was more significant when PE presented concomitant with cancer (p = 0.003) than when PE developed during cancer treatment (p = 0.206). CONCLUSIONS:PE is an important event in lung cancer patients which usually occurs in advanced disease and affects survival. In patients presenting PE at the initial diagnosis of cancer, the prognosis was the worst.

journal_name

Oncology

journal_title

Oncology

authors

Chuang YM,Yu CJ

doi

10.1159/000229503

subject

Has Abstract

pub_date

2009-01-01 00:00:00

pages

100-6

issue

2

eissn

0030-2414

issn

1423-0232

pii

000229503

journal_volume

77

pub_type

杂志文章

相关文献

ONCOLOGY文献大全
  • Capecitabine and mitomycin C is an effective combination for anthracycline- and taxane-resistant metastatic breast cancer.

    abstract::Capecitabine is converted to 5-fluorouracil by thymidine phosphorylase, and mitomycin C is capable of upregulating the expression of thymidine phosphorylase suggesting a synergistic effect. Fifty-three patients (median age 62 years) with anthracycline- and taxane-resistant, metastatic breast cancer received mitomycin ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000096250

    authors: Massacesi C,La Cesa A,Marcucci F,Pilone A,Rocchi MB,Zepponi L,Santini D,Tonini G,Burattini L

    更新日期:2006-01-01 00:00:00

  • Effects of cycloheximide on chromatin-bound and -unbound PCNA in HeLa cells.

    abstract::We examined the effects of cycloheximide on the amount of chromatin-bound and -unbound PCNA subpopulations in HeLa cells. The chromatin-bound PCNA content decreased rapidly in the presence of cycloheximide, whereas the reduction of the total amount of PCNA was minimal even 24 h after the treatment with cycloheximide. ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227500

    authors: Sasaki K,Kurose A,Uesugi N,Kato A

    更新日期:1995-09-01 00:00:00

  • Cytogenetic testing of mutagenic and radioprotective effects of mesna.

    abstract::The effects of mesna (sodium 2-mercaptoethane-sulfonate) on the frequency of sister chromatid exchange (SCE) and chromosomal aberrations were studied in PHA-stimulated lymphocytes in vitro. Our data give no evidence for either an increase of SCE or chromosomal aberrations and, thus, do not suggest a mutagenic or cance...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225745

    authors: Becher R,Kakati S,Gibas Z,Sandberg AA

    更新日期:1983-01-01 00:00:00

  • Histone deacetylase in chronic lymphocytic leukemia.

    abstract:BACKGROUND:Elevated histone deacetylase (HDAC) isoenzyme levels have been described in patients with carcinomas and leukemias. HDAC inhibitors (HDACi) have shown promise in the treatment of carcinomas and are currently under intense research. To make better use of HDACi in treating chronic lymphocytic leukemia (CLL), H...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000334577

    authors: Wang JC,Kafeel MI,Avezbakiyev B,Chen C,Sun Y,Rathnasabapathy C,Kalavar M,He Z,Burton J,Lichter S

    更新日期:2011-01-01 00:00:00

  • Two consecutive phase II studies of 5-fluorouracil/leucovorin/mitomycin C and of gemcitabine in patients with advanced biliary cancer.

    abstract:INTRODUCTION:Carcinoma of the biliary system is a rare tumor entity, and patients with advanced disease face a dismal prognosis. Because of the absence of standard chemotherapy for advanced biliary carcinoma, we have performed two consecutive studies to evaluate the clinical potential of 5-fluorouracil, leucovorin and ...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000011961

    authors: Raderer M,Hejna MH,Valencak JB,Kornek GV,Weinländer GS,Bareck E,Lenauer J,Brodowicz T,Lang F,Scheithauer W

    更新日期:1999-04-01 00:00:00

  • DNA-Sensing and Nuclease Gene Expressions as Markers for Colorectal Cancer Progression.

    abstract:OBJECTIVE:Oncogene-driven stress-related DNA damage has been observed in lesions of colon cancer. Furthermore, DNA sensors and nucleases are stimulated during active DNA damage and replication. However, their changes and influences with respect to cancer remain largely unknown. METHODS:The gene expression levels of cG...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000452281

    authors: Yang CA,Huang HY,Chang YS,Lin CL,Lai IL,Chang JG

    更新日期:2017-01-01 00:00:00

  • Male breast cancer: immunohistochemical subtypes and clinical outcome characterization.

    abstract:AIM:The aim of this study was to assess the molecular subtype profiles of male breast cancer (MBC) and subsequent clinical outcome using a validated 6-marker immunohistochemical panel. METHODS:A total of 43 cases of MBC were examined retrospectively using a semiquantitative immunohistochemical analysis of estrogen rec...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000341537

    authors: Sánchez-Muñoz A,Román-Jobacho A,Pérez-Villa L,Sánchez-Rovira P,Miramón J,Pérez D,Sáez MI,de Luque V,Medina L,Ramírez-Tortosa CL,Vicioso L,Medina JA,Ribelles N,Alba E

    更新日期:2012-01-01 00:00:00

  • Boron neutron capture therapy of cerebral gliomas. II. Utilization of the blood-brain barrier and tumor-specific antigens for the selective concentration of boron in gliomas.

    abstract::The use of the blood-brain barrier and of tumor-specific antibodies to concentrate boron selectivity in gliomas for neutron capture therapy is considered experimentally and theoretically. The time-dependent concentration of two anionic boranes, B12 H11 SH2- and B12 H11 SOSB12 H114-, in the blood, brain, and tumor of ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225073

    authors: Tolpin EI,Wellum GR,Dohan FC Jr,Kornblith PL,Zamenhof RG

    更新日期:1975-01-01 00:00:00

  • 5-Fluorouracil, high-dose folinic acid, and mitomycin C combination chemotherapy in advanced gastrointestinal adenocarcinomas. A pilot study.

    abstract::Fifteen patients, median age 64 years, presenting with advanced gastrointestinal adenocarcinomas, were included in this study. The treatment combination consisted of folinic acid (200 mg/m2, IV bolus injection) followed by 5-fluorouracil (5-FU; 400 mg/m2, 30-min infusion) for 5 consecutive days and mitomycin C (10 mg/...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226620

    authors: Becouarn Y,Brunet R,Bussières E,Marée D

    更新日期:1988-01-01 00:00:00

  • Targeted therapy in the treatment of metastatic renal cell cancer.

    abstract::The treatment of metastatic renal cell carcinoma (MRCC) has evolved from being predominantly cytokine-based to being grounded in the use of drugs targeting vascular endothelial growth factor, platelet-derived growth factor and mammalian target of rapamycin (mTOR) pathways. New agents including the small-molecule targe...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000258504

    authors: Di Lorenzo G,Scagliarini S,Di Napoli M,Scognamiglio F,Rizzo M,Carteni' G

    更新日期:2009-01-01 00:00:00

  • Characterization of vincristine-resistant HOB1 lymphoma cell line showing the classical MDR phenotype and altered expression of membrane glycoproteins.

    abstract::A multidrug-resistant (MDR) cell line isolated from HOB1 lymphoma cells was characterized. The MDR phenotype in this cell line was typified by resistance to vincristine with varying degrees of cross-resistance to Adriamycin, colcemid and actinomycin D. Decreased intracellular [3H]vincristine with concurrent increase i...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227300

    authors: Lee WP,Lee CL

    更新日期:1994-01-01 00:00:00

  • Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survival.

    abstract:OBJECTIVES:Anaplastic oligodendrogliomas (AO) are uncommon primary brain tumors whose natural history, prognosis, and optimal management are not yet fully understood. However, they are associated with a better prognosis and response to multimodality therapy based on specific molecular changes. In this multicenter retro...

    journal_title:Oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1159/000074479

    authors: Puduvalli VK,Hashmi M,McAllister LD,Levin VA,Hess KR,Prados M,Jaeckle KA,Yung WK,Buys SS,Bruner JM,Townsend JJ,Davis R,Sawaya R,Kyritsis AP

    更新日期:2003-01-01 00:00:00

  • Flow cytometric analysis of the DNA content of tumor cells in cases of gastric cancer in the upper third of the stomach and in the remnant stomach.

    abstract::Thirteen samples of gastric tumors that had developed in the remnant stomach (remnant gastric cancer) were compared with 63 samples of primary gastric tumors located in the upper third of the stomach (primary gastric cancer) by both clinicopathologic and flow cytometric analysis. The depths of invasion of all these tu...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227441

    authors: Ikeguchi M,Kondou A,Oka A,Tsujitani S,Maeta M,Kaibara N

    更新日期:1995-03-01 00:00:00

  • Distribution and timing of distant metastasis after local therapy in a large cohort of patients with esophageal and esophagogastric junction cancer.

    abstract:BACKGROUND:Patients with localized esophageal and esophagogastric junction cancer (EAC) receive chemoradiation and then surgery (trimodality, TMT) or definitive chemoradiation (bimodality, BMT). Distant metastases (DMs) are common but the details of their distribution and timing in a large cohort have not been describe...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000360703

    authors: Shiozaki H,Sudo K,Xiao L,Wadhwa R,Elimova E,Hofstetter WL,Skinner HD,Lee JH,Weston B,Bhutani MS,Blum MA,Maru DM,Ajani JA

    更新日期:2014-01-01 00:00:00

  • Surgical treatment and prognosis for patients with gastric cancer lesions larger than ten centimeters in size.

    abstract::In 323 of 1,620 patients with gastric cancer, the lesion was > or = 10 cm in maximum diameter. Studies were done with respect to clinicopathologic features and the prognosis. Patients with tumors > or = 10 cm were younger and women patients were more numerous compared to those with tumors < 10 cm. Tumors were more adv...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227424

    authors: Maehara Y,Oiwa H,Oda S,Sakaguchi Y,Endo K,Ohno S,Sugimachi K

    更新日期:1995-01-01 00:00:00

  • Inhibitory action of aminoglutethimide on DMBA-induced mammary carcinogenesis.

    abstract::The present communication reports the inhibitory action of aminoglutethimide on 9,10-dimethyl-1,2-benzanthracene (DMBA) induced mammary carcinogenesis in virgin female Holtzman rats. When 20 mg of DMBA is given to the rats and maintained on normal diet for 32 weeks, approximately 70% of the animals develop mammary tum...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226013

    authors: Rao AR,Das MG,Das P

    更新日期:1985-01-01 00:00:00

  • Impact of interferon therapy after curative treatment of hepatocellular carcinoma.

    abstract::Primary and secondary prevention of hepatocellular carcinoma (HCC) which has become endemic worldwide in recent years are the most important issues in reducing mortality of HCC patients. Among several compounds previously reported for secondary prevention, treatment with interferon (IFN) is widely applied and shows en...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000173422

    authors: Kudo M

    更新日期:2008-01-01 00:00:00

  • Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer.

    abstract::This study sought to examine the relationship between MUC1 expression at the deepest invasive portion, invasive/metastatic potential, and prognosis of colorectal cancer in relation to cellular proliferation. MUC1 expression was detected immunohistochemically using KL-6 antibody (anti-MUC1 monoclonal antibody) in 100 s...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000011868

    authors: Hiraga Y,Tanaka S,Haruma K,Yoshihara M,Sumii K,Kajiyama G,Shimamoto F,Kohno N

    更新日期:1998-07-01 00:00:00

  • Locoregional Control and Toxicity in Head and Neck Carcinoma Patients following Helical Tomotherapy-Delivered Intensity-Modulated Radiation Therapy Compared with 3D-CRT Data.

    abstract:OBJECTIVES:To assess the feasibility and efficacy of intensity-modulated radiation implemented with helical tomotherapy image-guided with daily megavoltage computed tomography for head and neck cancer. METHODS:Between May 2010 and May 2013, 72 patients were treated with curative intent. The median age was 64 years, wi...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000489217

    authors: Santa Cruz O,Tsoutsou P,Castella C,Khanfir K,Anchisi S,Bouayed S,Matzinger O,Ozsahin M

    更新日期:2018-01-01 00:00:00

  • Phase I/II study of twenty-four-hour infusion of irinotecan in combination with oral UFT plus leucovorin for metastatic colorectal cancer.

    abstract:OBJECTIVE:Irinotecan has, in general, been administered as a 90-min infusion. However, several studies have demonstrated that continuous infusion seems to be a promising method of delivering irinotecan. This phase I/II trial was performed to evaluate the efficacy and safety of continuous infusion of irinotecan combined...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000209963

    authors: Sadahiro S,Suzuki T,Maeda Y,Tanaka A,Ishikawa K,Makuuchi H,Murayama C

    更新日期:2009-01-01 00:00:00

  • Epirubicin is More Effective than Miriplatin in Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma.

    abstract:BACKGROUND:Transcatheter arterial chemoembolization (TACE) is a standard therapy used in the treatment of intermediate hepatocellular carcinoma (HCC). Recently, balloon-occluded TACE (B-TACE) has been developed. PURPOSE:This study aimed to clarify the effects of B-TACE in patients with HCC, with a focus on which drug ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000492822

    authors: Shirono T,Iwamoto H,Niizeki T,Shimose S,Nakano M,Satani M,Okamura S,Noda Y,Kamachi N,Kuromatsu R,Sakai M,Nomiyama M,Kuwano T,Tanaka M,Koga H,Torimura T

    更新日期:2019-01-01 00:00:00

  • Long-Term Survival and Cure in Distant Metastatic Breast Cancer.

    abstract:BACKGROUND:Previous data showed that distant metastatic breast cancer (MBC) might be curable in up to 3% of the cases in selected patients, mostly young, with good performance status and with low-volume metastatic disease, mainly by an aggressive multidisciplinary approach including aggressive combination chemotherapy ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000500298

    authors: Güth U,Elfgen C,Montagna G,Schmid SM

    更新日期:2019-01-01 00:00:00

  • Assessment of an in vitro screening test of cytotoxic agents in the treatment of advanced malignant disease.

    abstract::The value of a screening test for sytoxic chemotherapeutic agents in the treatment of advanced malignant disease is assessed by comparing the performances of 32 patients whose treatment followed closely the test recommendations with that of 31 patients whose treatment did not follow the predictions. The significant im...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000224977

    authors: Wheeler TK,Dendy PP,Dawson A

    更新日期:1974-01-01 00:00:00

  • EUS-Guided Pancreatic Duct Drainage for Repeat Pancreatitis in a Patient with Pancreatic Cancer.

    abstract::Endoscopic ultrasound-guided pancreatic drainage (EUS-PD) was performed in a patient with unresectable pancreatic cancer who developed pancreatitis. In this case, EUS-PD was useful as salvage therapy for pancreatitis as the transpapillary approach was difficult. ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000481238

    authors: Kamata K,Takenaka M,Minaga K,Sakurai T,Watanabe T,Nishida N,Kudo M

    更新日期:2017-01-01 00:00:00

  • Cooccurrence of reduced expression of alpha-catenin and overexpression of p53 is a predictor of lymph node metastasis in early gastric cancer.

    abstract:BACKGROUND AND OBJECTIVES:Even though the pathological background contributes to lymph node metastasis, the biological characteristics of tumors have also gained wide attention. In this study, the expression of the cadherin-catenin complex and p53 was studied in early gastric cancer. Their correlation with lymph node m...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000012020

    authors: Xiangming C,Hokita S,Natsugoe S,Tanabe G,Baba M,Takao S,Kuroshima K,Aikou T

    更新日期:1999-01-01 00:00:00

  • Development of cytotoxic cells during in vitro cultures of pleural effusion lymphocytes from patients with lung cancer.

    abstract::Culture-induced cytotoxic (CIC) activity developed in 7-day culture in the presence of fetal calf serum of pleural effusion lymphocytes from patients with lung cancer which initially showed markedly low or no natural killing (NK) activity against K562 cells. The development of CIC activity was proliferation-dependent....

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225637

    authors: Uchida A,Micksche M

    更新日期:1982-01-01 00:00:00

  • HER-targeted tyrosine-kinase inhibitors.

    abstract::Improved understanding of tumor biology has led to the identification of numerous growth factors that are involved in malignant transformation and tumor progression. Many of these factors induce cellular responses through receptors with intrinsic tyrosine kinase (TK) activity. Therefore, inhibiting receptor TK activit...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000066198

    authors: Baselga J,Hammond LA

    更新日期:2002-01-01 00:00:00

  • Antiemetic efficacy of moderately high-dose metoclopramide in patients receiving varying doses of cisplatin. Controlled comparison with a combination of methylprednisolone and metoclopramide.

    abstract::In 29 patients (48 courses of chemotherapy), a randomized double-blind crossover study was undertaken to establish the antiemetic effectiveness of a combination of metoclopramide at a moderately high dose (5 mg/kg body weight) with 1 g methylprednisolone (treatment A) as compared with metoclopramide monotherapy (5 mg/...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000226063

    authors: Ell C,König HJ,Brockmann P,Domschke S,Domschke W

    更新日期:1985-01-01 00:00:00

  • Risk factors of metastasis in oral squamous cell carcinomas.

    abstract::Lymph node and distant metastasis were comparatively studied in 225 oral carcinomas, and factors predisposing toward metastasis were investigated using clinical and immunohistopathological approaches. Neither the sites of tumors nor T-stage was correlated with either type of metastasis. Tumor cell differentiation was ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000012090

    authors: Osaki T,Kimura T,Tatemoto Y,Yamamoto T,Yoneda K

    更新日期:2000-02-01 00:00:00

  • Functionally active duplications of the CYP2D6 gene are more prevalent among larynx and lung cancer patients.

    abstract::The cytochrome P450 CYP2D6 is a polymorphic drug-metabolizing enzyme that is involved in the metabolism of several drugs and xenobiotics. Several independent studies indicate that the CYP2D6 metabolic status is a secondary factor in the risk of developing lung cancer, with individuals with high activity being at incre...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000055354

    authors: Agúndez JA,Gallardo L,Ledesma MC,Lozano L,Rodriguez-Lescure A,Pontes JC,Iglesias-Moreno MC,Poch J,Ladero JM,Benítez J

    更新日期:2001-01-01 00:00:00